BioSpace News Archive

Tennessee Hemp Company to Launch Products and Open Retail Locations in 2019

AR101 Associated with 70% Reduction in Allergic Reactions Due to Accidental Exposures That Required Treatment Compared to Placebo After Dose Escalation in PALISADE

Gracell addresses the issues of complex manufacture and high cost of cellular gene therapeutics

The conference presentation will be webcast live and may be accessed by visiting Horizon’s website at http://ir.horizon-pharma.com.

Data in non-human primates from C100 program show potent stem and immune cell depletion with anti-CD45 amanitin ADC that is well tolerated at efficacious doses

The company has acquired American Personnel Staffing’s BioSciences Division to strengthen its position within that key industry sector.

The Washington Mesothelioma Victims Center says, “We are appealing to a person with recently diagnosed mesothelioma or asbestos exposure lung cancer anywhere in Washington State to get serious about their financial compensation and to call us anytime at 800-714-0303 for direct access to attorney Erik Karst founding partner of the law firm Karst von Oiste.

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NYSE: CGC) is pleased to announce it has named Hilary Black as its Chief Advocacy Officer, effective immediately.

China Biologic Products Holdings, Inc. (NASDAQ: CBPO) (“China Biologic” or the “Company”), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release its fourth quarter and fiscal year 2018 financial results on Wednesday, March 6, 2019 after the market closes.

Heritage Provider Network (HPN), one of the nation’s leading physician-led managed care organizations, and Crain’s Custom, a division of Crain’s New York Business, have selected a prestigious panel of judges to evaluate candidates for the annual Heritage Healthcare Innovation Awards